Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Ravindre Panchia

Biographic Data

ID7728716
NAMERavindre Panchia
GIVEN NAMESRavindre
FAMILY NAMEPanchia
SIGNATUREPANCHIA R
AFFILIATIONSUniversity of the Witwatersrand
ORCID0000-0002-3601-0839
VERIFIEDYes
TOTAL WORKS12
TOTAL CITATIONS0
WORKS AS AUTHOR12
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2014
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Stigma and other correlates of self-esteem and depression in cisgender men and transfeminine persons with HIV who have sex with men in Kenya, Malawi, and South Africa (HPTN 075)

    Open Access•Erica L Hamilton, Xu Guo et al.•ARTICLE•AIDS Care•2025

    HIV-related stigma profoundly impacts individuals living with HIV, hindering self-esteem and access to treatment. Few studies, if any, have assessed the effects of stigma on depression and self-esteem among men who have sex with men (MSM) and transfeminine persons (TFP) with HIV in African settings. We explored factors, including various forms of stigma, contributing to low self-esteem and poor mental health among 71 MSM and TFP in Kenya, Malawi,…

  • The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition

    Open Access•James Stannah, Jesse Knight et al.•ARTICLE•AIDS and Behavior•2025

  • Comparison of Self-Reported Substance Use with Outcomes of Urine Testing among Men Who Have Sex with Men in Africa Participating in HPTN 075

    Open Access•Theo Sandfort, Susan H Eshleman et al.•ARTICLE•AIDS and Behavior•2025

    Research linking substance use with HIV risk behaviors and antiretroviral therapy adherence is typically based on self-reported data. However, studies in high-income countries show that men who have sex with men (MSM) often underreport substance use when compared to objective biological testing. Such comparisons have not been conducted among MSM in sub-Saharan Africa. We compared self-reported and objectively measured substance use among MSM part…

  • Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa

    Open Access•Theo Sandfort, Philip Kreniske et al.•ARTICLE•AIDS and Behavior•2024

  • Interest in Oral Pre-exposure Prophylaxis Among Men Who Have Sex with Men and Transfeminine Persons in HPTN 075, a Multi-center HIV Prevention Study in Sub-Saharan Africa (2015–2017)

    Open Access•Joseph Orinda, Joseph O Orinda et al.•ARTICLE•AIDS and Behavior•2024

  • Bisexuality among Men who have Sex with Men in Sub-Saharan Africa

    Open Access•Ken Ondenge, Xu Guo et al.•ARTICLE•AIDS and Behavior•2024

  • HIV risk perception and sexual behavior among HIV-uninfected men and transgender women who have sex with men in sub-Saharan Africa

    Open Access•Yamikani R Mbilizi Chimwaza, Sufia Dadabhai et al.•ARTICLE•PLOS Global Public Health•2022

    There remains a limited understanding of how men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa (SSA) perceive their risk for HIV and how risk influences behavior during sexual interactions. We performed thematic analysis on in-depth interviews from the qualitative sub-study of HPTN 075 in Kenya, Malawi, and South Africa. Using the Integrated Behavioral Model (IBM) constructs, we found that most MSM and TGW perceive…

  • Healthcare-related stigma among men who have sex with men and transgender women in sub-Saharan Africa participating in HIV Prevention Trials Network (HPTN) 075 study

    Calvin Mbeda, Arthur Ogendo et al.•ARTICLE•AIDS Care•2020

    The inability to access health services when needed is a critical barrier to HIV prevention, treatment and care among men who have sex with men (MSM) and transgender women (TGW). Using data collected in HPTN 075, we explored factors associated with any experienced healthcare-related stigma. HPTN 075 was a cohort study to assess the feasibility of recruiting and retaining MSM and TGW in clinical trials in sub-Saharan Africa. Of 401 MSM and TGW enr…

  • Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals

    Open Access•Elizabeth E Tolley, Sahar Z Zangeneh et al.•ARTICLE•AIDS and Behavior•2020

    Long-acting injectable PrEP could offer an alternative to daily oral PrEP, improve adherence and protection, if found acceptable, safe and effective. HPTN 077 evaluated injectable cabotegravir safety, tolerability and pharmacokinetics among HIV-uninfected males and females in sequentially-enrolled cohorts of two dosing strategies. We compared acceptability of product attributes, prevention preferences and future interest in injectable PrEP (FIIP)…

  • Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study

    Open Access•Jessica M Fogel, Theo Sandfort et al.•ARTICLE•AIDS and Behavior•2018

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S Cohen, Ying Qing Chen et al.•ARTICLE•New England Journal of Medicine•2016

    BACKGROUND: An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused by human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. ART was then offered to all patients with HIV-1 infection (index participants). The study included more than 5 years of follow-up to assess the durability of such therapy for …

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection

    Open Access•Beatriz Gilda Jegerhorn Grinsztejn, Beatriz Grinsztejn et al.•ARTICLE•The Lancet Infectious Diseases•2014

No prominent works on this page.

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection

    Open Access•Beatriz Gilda Jegerhorn Grinsztejn, Beatriz Grinsztejn et al.•ARTICLE•The Lancet Infectious Diseases•2014

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S Cohen, Ying Qing Chen et al.•ARTICLE•New England Journal of Medicine•2016

    BACKGROUND: An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused by human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. ART was then offered to all patients with HIV-1 infection (index participants). The study included more than 5 years of follow-up to assess the durability of such therapy for …

  • Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study

    Open Access•Jessica M Fogel, Theo Sandfort et al.•ARTICLE•AIDS and Behavior•2018

  • Healthcare-related stigma among men who have sex with men and transgender women in sub-Saharan Africa participating in HIV Prevention Trials Network (HPTN) 075 study

    Calvin Mbeda, Arthur Ogendo et al.•ARTICLE•AIDS Care•2020

    The inability to access health services when needed is a critical barrier to HIV prevention, treatment and care among men who have sex with men (MSM) and transgender women (TGW). Using data collected in HPTN 075, we explored factors associated with any experienced healthcare-related stigma. HPTN 075 was a cohort study to assess the feasibility of recruiting and retaining MSM and TGW in clinical trials in sub-Saharan Africa. Of 401 MSM and TGW enr…

  • Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals

    Open Access•Elizabeth E Tolley, Sahar Z Zangeneh et al.•ARTICLE•AIDS and Behavior•2020

    Long-acting injectable PrEP could offer an alternative to daily oral PrEP, improve adherence and protection, if found acceptable, safe and effective. HPTN 077 evaluated injectable cabotegravir safety, tolerability and pharmacokinetics among HIV-uninfected males and females in sequentially-enrolled cohorts of two dosing strategies. We compared acceptability of product attributes, prevention preferences and future interest in injectable PrEP (FIIP)…

  • HIV risk perception and sexual behavior among HIV-uninfected men and transgender women who have sex with men in sub-Saharan Africa

    Open Access•Yamikani R Mbilizi Chimwaza, Sufia Dadabhai et al.•ARTICLE•PLOS Global Public Health•2022

    There remains a limited understanding of how men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa (SSA) perceive their risk for HIV and how risk influences behavior during sexual interactions. We performed thematic analysis on in-depth interviews from the qualitative sub-study of HPTN 075 in Kenya, Malawi, and South Africa. Using the Integrated Behavioral Model (IBM) constructs, we found that most MSM and TGW perceive…

  • Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa

    Open Access•Theo Sandfort, Philip Kreniske et al.•ARTICLE•AIDS and Behavior•2024

  • Interest in Oral Pre-exposure Prophylaxis Among Men Who Have Sex with Men and Transfeminine Persons in HPTN 075, a Multi-center HIV Prevention Study in Sub-Saharan Africa (2015–2017)

    Open Access•Joseph Orinda, Joseph O Orinda et al.•ARTICLE•AIDS and Behavior•2024

  • Bisexuality among Men who have Sex with Men in Sub-Saharan Africa

    Open Access•Ken Ondenge, Xu Guo et al.•ARTICLE•AIDS and Behavior•2024

  • Stigma and other correlates of self-esteem and depression in cisgender men and transfeminine persons with HIV who have sex with men in Kenya, Malawi, and South Africa (HPTN 075)

    Open Access•Erica L Hamilton, Xu Guo et al.•ARTICLE•AIDS Care•2025

    HIV-related stigma profoundly impacts individuals living with HIV, hindering self-esteem and access to treatment. Few studies, if any, have assessed the effects of stigma on depression and self-esteem among men who have sex with men (MSM) and transfeminine persons (TFP) with HIV in African settings. We explored factors, including various forms of stigma, contributing to low self-esteem and poor mental health among 71 MSM and TFP in Kenya, Malawi,…

  • The Effect of Sexual and Gender Minority Violence on Depression, Hazardous Drinking, Condom Use, and HIV Acquisition

    Open Access•James Stannah, Jesse Knight et al.•ARTICLE•AIDS and Behavior•2025

  • Comparison of Self-Reported Substance Use with Outcomes of Urine Testing among Men Who Have Sex with Men in Africa Participating in HPTN 075

    Open Access•Theo Sandfort, Susan H Eshleman et al.•ARTICLE•AIDS and Behavior•2025

    Research linking substance use with HIV risk behaviors and antiretroviral therapy adherence is typically based on self-reported data. However, studies in high-income countries show that men who have sex with men (MSM) often underreport substance use when compared to objective biological testing. Such comparisons have not been conducted among MSM in sub-Saharan Africa. We compared self-reported and objectively measured substance use among MSM part…

HIV/AIDS Research and Interventions (12 works) · Medicine (11 works) · Men who have sex with men (9 works) · Psychology (8 works) · Health psychology (6 works) · HIV, Drug Use, Sexual Risk (6 works) · Human immunodeficiency virus (HIV (6 works) · Public health (6 works) · Family medicine (5 works) · HIV Research and Treatment (5 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae